TreeFrog Therapeutics
Created in 2018
- BETA
Trend leader (A+)
Existing signals make this entity one of the most dynamic startups Social networks
913 18,448Global tags
Activities
Technologies
Entity types
Location
30 Av. Gustave Eiffel Bat A, 33600 Pessac, France
Pessac
France
Employees
Scale: 51-200
Estimated: 151
SIREN
343619102Engaged corporates
38
15 26Added in Motherbase
4 years, 11 months ago
deeptech Value proposition
Cell Therapy for All
TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients.
TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality.
Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinson's Disease. In 2022, the company opened a technological hub in Boston, USA to drive the adoption of C-Stem and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy.
Cell Therapy, Stem Cell, Stem cell mass-production, Cell therapy cGMP manufacturing, biomimetic 3D cell culture, and bioreactor stem cell cultivationOriginal language
Cell Therapy for All
TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients.
TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality.
Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinson's Disease. In 2022, the company opened a technological hub in Boston, USA to drive the adoption of C-Stem and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy.
TreeFrog Therapeutics I iPS-derived Cell Therapies I Cell Therapy for All
TreeFrog Therapeutics aims at making iPS-derived cell therapies safer, more efficient and more affordable to cure millions of patients.
https://treefrog.fr/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Leem Startup accelerator & VC, Pharmaceutical Manufacturing | Leem Startup accelerator & VC, Pharmaceutical Manufacturing | Other 17 Nov 2020 12 Feb 2024 | | |
 France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 22 May 2024 | | |
 Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Other 22 May 2024 | | |
 CNRS Innovation Research, Research Services | CNRS Innovation Research, Research Services | Other 21 Feb 2023 | | |
 AQUITI Gestion Startup accelerator & VC, Venture Capital and Private Equity Principals | AQUITI Gestion Startup accelerator & VC, Venture Capital and Private Equity Principals | Not capitalistic Partnership Event 22 May 2024 | | |
 Vertex Pharmaceuticals Biotechnology, Biotechnology Research | Vertex Pharmaceuticals Biotechnology, Biotechnology Research | Other 14 Jan 2021 19 Jul 2024 | | |
 INVIVOLIM Biotechnology, Biotechnology Research | INVIVOLIM Biotechnology, Biotechnology Research | Not capitalistic Not partnership Event 15 May 2019 | | |
 UNITEC IT Services and IT Consulting | UNITEC IT Services and IT Consulting | Not capitalistic Partnership Event 28 Jun 2024 | | |